Literature DB >> 6194313

Comparison of the major antigenic determinants of different serotypes of foot-and-mouth disease virus.

A Cheung, J DeLamarter, S Weiss, H Küpper.   

Abstract

Complete nucleotide sequences which code for the capsid protein VP1 of two foot-and-mouth disease virus serotypes, O1Campos/Brazil/58 and C3Indaial/Brazil/71, have been determined. Ten available VP1 sequences (three serotype O, three serotype C, and four serotype A) were aligned and compared. Our evidence suggests that O1BFS/Britain/68 and O1K/Germany/66 are closely related to O1Campos/Brazil/58. Significant variations were observed between the nucleotide sequences of C3Indaial determined by two different laboratories. These differences are probably the result of virus adaptation and propagation in different laboratories. In one of the isolates (C3Biogen), a 13-base-pair stem and 13-base-pair loop structure is located in the 134-158 amino acid variable region. Isolates of different serotypes differ at two highly variable regions, amino acid positions 42-60 and 134-158, but isolates of the same serotype show major differences only in the variable region between amino acids 134 and 158. Since the remaining amino acid sequence of VP1 is highly conserved, we conclude that the 134-158 amino acid variable region is involved in subtype specificity, whereas both variable regions contribute to serotype differences.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6194313      PMCID: PMC255370     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene.

Authors:  M Grunstein; D S Hogness
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

2.  N-terminal amino acid sequences in the major capsid proteins of foot-and-mouth disease virus types A, O, and C.

Authors:  H D Matheka; H L Bachrach
Journal:  J Virol       Date:  1975-11       Impact factor: 5.103

3.  An experimental subunit vaccine for foot-and-mouth disease.

Authors:  H L Bachrach; D M Moore; P D McKercher; J Polatnick
Journal:  Dev Biol Stand       Date:  1976

4.  [Neutralization of the infective power of the foot-and-mouth disease virus in cell culture by using serums from pigs immunized with a purified viral protein].

Authors:  J Laporte; J Grosclaude; J Wantyghem; S Bernard; P Rouzé
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1973-06-18

5.  Isolation of the structural polypeptides of foot-and-mouth disease virus and analysis of their C-terminal sequences.

Authors:  H L Bachrach; J B Swaney; G F Vande Woude
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

6.  Further evidence for multiple proteins in the foot-and-mouth disease virus particle.

Authors:  J N Burroughs; D J Rowlands; D V Sangar; P Talbot; F Brown
Journal:  J Gen Virol       Date:  1971-10       Impact factor: 3.891

7.  Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus.

Authors:  H L Bachrach; D M Moore; P D McKercher; J Polatnick
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

8.  Biochemical mapping of the foot-and-mouth disease virus genome.

Authors:  D V Sangar; D N Black; D J Rowlands; F Brown
Journal:  J Gen Virol       Date:  1977-05       Impact factor: 3.891

9.  Immunogenicity of namogram to milligram quantities of inactivated foot-and-mouth disease virus. I. Relative virus-neutralizing potency of guinea pig sera.

Authors:  D O Morgan; H L Bachrach; P D McKercher
Journal:  Appl Microbiol       Date:  1969-03

10.  Induction of neutralizing antibodies and immunity in vaccinated guinea pigs by cyanogen bromide-peptides of VP3 of foot-and-mouth disease virus.

Authors:  O R Kaaden; K H Adam; K Strohmeier
Journal:  J Gen Virol       Date:  1977-02       Impact factor: 3.891

View more
  20 in total

1.  Foot-and-mouth disease virus O1Lombardy is biochemically related to O2 isolates.

Authors:  O Krebs; H G Berger; W Niedbalski; O Marquardt
Journal:  Virus Genes       Date:  1991-07       Impact factor: 2.332

2.  Sequences of capsid protein VP1 of two type A foot-and-mouth disease viruses.

Authors:  O Marquardt; K H Adam
Journal:  Virus Genes       Date:  1989-05       Impact factor: 2.332

Review 3.  Development of foot-and-mouth disease virus strain characterisation--a review.

Authors:  R P Kitching; N J Knowles; A R Samuel; A I Donaldson
Journal:  Trop Anim Health Prod       Date:  1989-08       Impact factor: 1.559

4.  Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein.

Authors:  H M Geysen; S J Barteling; R H Meloen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

5.  Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination.

Authors:  E Beck; K Strohmaier
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

6.  Antigenic variation in Foot and Mouth Disease Virus type Asia 1 isolates circulated during 1993-95 in India.

Authors:  P Tulasiram; M Tyagi; K Srinivas; K Prabhudas; C Natarajan; V Suryanarayana
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

7.  Phylogenetic analysis of foot-and-mouth disease viruses isolated in Argentina.

Authors:  G König; C Blanco; N J Knowles; E L Palma; E Maradei; M E Piccone
Journal:  Virus Genes       Date:  2001       Impact factor: 2.332

8.  Method to map antigenic determinants recognized by monoclonal antibodies: localization of a determinant of virus neutralization on the feline leukemia virus envelope protein gp70.

Authors:  J H Nunberg; G Rodgers; J H Gilbert; R M Snead
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  The capsid protein-encoding sequence of foot-and-mouth disease virus O2Brescia.

Authors:  O Krebs; H G Berger; O Marquardt
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

10.  Modification of foot-and-mouth disease virus O1 Caseros after serial passages in the presence of antiviral polyclonal sera.

Authors:  E R Rojas; E Carrillo; M Schiappacassi; R Campos
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.